Skip to content

Measurement of Body Fat in Infants

Measurement of Body Fat in Infants

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03490227
Acronym
Baby Fat Pilot
Enrollment
10
Registered
2018-04-06
Start date
2018-04-30
Completion date
2019-12-02
Last updated
2021-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Composition, Brown Adipose Tissue

Keywords

neonates, brown adipose tissue, body composition

Brief summary

Up to 10 infants will complete the study aimed to establish a technique for measuring whole body adiposity and brown adipose tissue in infant subjects using dual energy x-ray absorptiometry and magnetic resonance imaging, respectively.

Interventions

None listed

Sponsors

Pennington Biomedical Research Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
14 Days to 28 Days
Healthy volunteers
Yes

Inclusion criteria

* healthy, full-term infant * aged 14-28 days at Visit 1

Exclusion criteria

* born preterm (\<37 weeks gestation) * implanted metal or electronic objects that render MRI unsafe * unable to complete 2 clinic visits 1-10 days apart at Pennington Biomedical Research Center

Design outcomes

Primary

MeasureTime frameDescription
Whole Body Fat Mass1 dayWhole body fat mass will be measured in infant subjects using dual energy x-ray absorptiometry.
Average Brown Adipose Tissue Volume at First Visit1 dayMagnetic resonance imaging were traced for lipid: water ratio in the supraclavicular region. Brown adipose tissue volume was calculated by summing all brown adipose tissue volume in the supraclavicular region with a lipid: water ration (or fat signal fraction) between 10-50%.
Average Brown Adipose Tissue Volume at Second Visit1 dayMagnetic resonance imaging were traced for lipid: water ratio in the supraclavicular region. Brown adipose tissue volume was calculated by summing all brown adipose tissue volume in the supraclavicular region with a lipid: water ration (or fat signal fraction) between 10-50%.

Secondary

MeasureTime frameDescription
Average Fat Signal Fraction of Brown Adipose Tissue at First Visit1 dayMagnetic resonance imaging scans were traced for lipid: water ratio in the supraclavicular region. Fat signal fraction is defined as the lipid: water ratio found in the lipid tissues in the supraclavicular region. Only traced lipid tissues (between 10-50%) were included in the average fat signal fraction because only traced lipid tissues were classified as brown adipose tissue.
Average Fat Signal Fraction of Brown Adipose Tissue at Second Visit1 dayMagnetic resonance imaging scans were traced for lipid: water ratio in the supraclavicular region. Fat signal fraction is defined as the lipid: water ratio found in the lipid tissues in the supraclavicular region. Only traced lipid tissues (between 10-50%) were included in the average fat signal fraction because only traced lipid tissues were classified as brown adipose tissue.
Reliability of Average Brown Adipose Tissue Volume Measurement Between the First and Second Visit2 days within 10 days apartReliability of average brown adipose tissue volume measurement between visits was determined using intraclass correlation coefficient. Paired average brown adipose tissue volume measurements were included in the intraclass correlation coefficient computation.

Countries

United States

Participant flow

Participants by arm

ArmCount
All Participants
This is an observational study where all participants did DXA once and MRI twice in order to assess infant body composition and brown adipose tissue.
10
Total10

Baseline characteristics

CharacteristicAll Participants
Age, Continuous22.6 days
STANDARD_DEVIATION 1.31
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
8 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
2 Participants
Gestational Age at Birth39.129 weeks
STANDARD_DEVIATION 1.296
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
1 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
9 Participants
Sex: Female, Male
Female
3 Participants
Sex: Female, Male
Male
7 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 10
other
Total, other adverse events
1 / 10
serious
Total, serious adverse events
0 / 10

Outcome results

Primary

Average Brown Adipose Tissue Volume at First Visit

Magnetic resonance imaging were traced for lipid: water ratio in the supraclavicular region. Brown adipose tissue volume was calculated by summing all brown adipose tissue volume in the supraclavicular region with a lipid: water ration (or fat signal fraction) between 10-50%.

Time frame: 1 day

Population: One scan was not analyzed. The scan was completed but did not provide valid data.

ArmMeasureValue (MEAN)Dispersion
All ParticipantsAverage Brown Adipose Tissue Volume at First Visit5.41 cubic centimetersStandard Deviation 0.88
Primary

Average Brown Adipose Tissue Volume at Second Visit

Magnetic resonance imaging were traced for lipid: water ratio in the supraclavicular region. Brown adipose tissue volume was calculated by summing all brown adipose tissue volume in the supraclavicular region with a lipid: water ration (or fat signal fraction) between 10-50%.

Time frame: 1 day

ArmMeasureValue (MEAN)Dispersion
All ParticipantsAverage Brown Adipose Tissue Volume at Second Visit5.50 cubic centimetersStandard Deviation 1.3
Primary

Whole Body Fat Mass

Whole body fat mass will be measured in infant subjects using dual energy x-ray absorptiometry.

Time frame: 1 day

ArmMeasureValue (MEAN)Dispersion
All ParticipantsWhole Body Fat Mass20.8 percentage of fat massStandard Deviation 1.8
Secondary

Average Fat Signal Fraction of Brown Adipose Tissue at First Visit

Magnetic resonance imaging scans were traced for lipid: water ratio in the supraclavicular region. Fat signal fraction is defined as the lipid: water ratio found in the lipid tissues in the supraclavicular region. Only traced lipid tissues (between 10-50%) were included in the average fat signal fraction because only traced lipid tissues were classified as brown adipose tissue.

Time frame: 1 day

Population: One scan was not analyzed. The scan was completed but did not provide valid data.

ArmMeasureValue (MEAN)Dispersion
All ParticipantsAverage Fat Signal Fraction of Brown Adipose Tissue at First Visit16.64 Percentage of lipidStandard Deviation 3.31
Secondary

Average Fat Signal Fraction of Brown Adipose Tissue at Second Visit

Magnetic resonance imaging scans were traced for lipid: water ratio in the supraclavicular region. Fat signal fraction is defined as the lipid: water ratio found in the lipid tissues in the supraclavicular region. Only traced lipid tissues (between 10-50%) were included in the average fat signal fraction because only traced lipid tissues were classified as brown adipose tissue.

Time frame: 1 day

ArmMeasureValue (MEAN)Dispersion
All ParticipantsAverage Fat Signal Fraction of Brown Adipose Tissue at Second Visit16.43 Percentage of lipidStandard Deviation 3.41
Secondary

Reliability of Average Brown Adipose Tissue Volume Measurement Between the First and Second Visit

Reliability of average brown adipose tissue volume measurement between visits was determined using intraclass correlation coefficient. Paired average brown adipose tissue volume measurements were included in the intraclass correlation coefficient computation.

Time frame: 2 days within 10 days apart

Population: One scan was not analyzed. The scan was completed but did not provide valid data.

ArmMeasureValue (NUMBER)
All ParticipantsReliability of Average Brown Adipose Tissue Volume Measurement Between the First and Second Visit0.92 intraclass correlation coefficient

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026